Given a free T4 of 0.88 ng/dL (normal), TSH of 1.525 µU/mL (normal), and free T3 of 11.37 pg/mL (elevated), what is the likely diagnosis and recommended management?

Laboratory Assay Interference is the Most Likely Explanation

This pattern of markedly elevated free T3 (11.37 pg/mL, nearly 3x upper limit) with normal TSH (1.525 µU/mL) and normal free T4 (0.88 ng/dL) strongly suggests laboratory assay interference rather than true thyroid disease, and the first step is to repeat testing on a different immunoassay platform.

Diagnostic Reasoning

According to American Thyroid Association/American Association of Clinical Endocrinologists guidelines, in the absence of TSH-producing pituitary adenoma or thyroid hormone resistance, if serum TSH is normal, the patient is almost never hyperthyroid 1. This is a critical principle that makes true hyperthyroidism extremely unlikely in this case.

Why This Pattern is Inconsistent with True Thyroid Disease

The laboratory results show:

• Normal TSH: Rules out primary thyroid dysfunction
• Normal free T4: Rules out typical hyperthyroidism
• Isolated marked elevation of free T3: Physiologically implausible pattern

True T3-toxicosis (isolated T3 elevation with hyperthyroidism) would present with:

• Suppressed TSH (<0.01 µU/mL), not normal TSH 1
• Clinical signs of thyrotoxicosis (tachycardia, weight loss, heat intolerance)
• Usually occurs in early Graves' disease or toxic nodular goiter 1

Laboratory Assay Interference

Free T3 assays are less widely validated than free T4 assays 1, making them more susceptible to interference. Common causes of spurious free T3 elevation include:

• Heterophilic antibodies (including anti-thyroid antibodies like anti-TPO, anti-thyroglobulin) 1, 2
• Immunoglobulin interference that directly binds T3 1
• Platform-specific assay artifacts 2, 3

A 2012 case report documented a patient with Hashimoto's thyroiditis where free T4 measured 4.59 ng/dL on Roche® platform but only 1.08 ng/dL on Abbott® platform, confirming assay interference 2. The 2026 study showed discordance between total T3 and free T3 measurements in 13 of 41 patients with elevated T3 values 3.

Recommended Management Algorithm

Step 1: Immediate Actions

• Repeat thyroid function tests on a different immunoassay platform (e.g., if initially tested on Roche®, retest on Abbott® or Siemens®) 2
• Measure total T3 instead of free T3, as it is less affected by assay interference 1, 3
• Clinical assessment: Look specifically for signs of thyrotoxicosis:
  • Tachycardia (resting heart rate >90 bpm)
  • Unintentional weight loss
  • Heat intolerance, excessive sweating
  • Tremor, anxiety
  • Thyroid enlargement or nodules

Step 2: If Assay Interference is Confirmed (Most Likely)

• No treatment required if repeat testing on alternative platform shows normal free T3
• Document the interference in medical records to prevent future confusion
• Consider testing for anti-thyroid antibodies (anti-TPO, anti-thyroglobulin) as these can cause assay interference 2

Step 3: If Elevated Free T3 Persists on Multiple Platforms (Unlikely)

Only if TSH remains normal with persistently elevated free T3:

• Investigate for rare causes:
  • TSH-producing pituitary adenoma: Order pituitary MRI and alpha-subunit of glycoprotein hormones 1
  • Thyroid hormone resistance: Obtain family history and consider genetic testing for T3-receptor mutations 1
  • Medication review: Amiodarone, high-dose propranolol, certain psychiatric medications 1
  • Familial dysalbuminemic hyperthyroxinemia or other binding protein abnormalities 1

Step 4: If Clinical Hyperthyroidism is Present Despite Normal TSH

• Radioactive iodine uptake scan to differentiate causes 1
• Measure TSH receptor antibodies (TRAb) for Graves' disease
• Thyroid ultrasound to evaluate for nodules

Critical Pitfalls to Avoid

1. Do not treat based on a single abnormal free T3 result with normal TSH - this will cause iatrogenic hypothyroidism
2. Do not assume T3-toxicosis without suppressed TSH - true T3-toxicosis requires TSH <0.01 µU/mL 1
3. Do not order extensive workup before confirming the abnormality on a different platform - assay interference is far more common than rare endocrine disorders
4. Free T3 assays are inherently less reliable than free T4 assays - always correlate with clinical picture 1, 4

Bottom Line

The combination of normal TSH and normal free T4 makes true hyperthyroidism extraordinarily unlikely 1. Repeat testing on a different immunoassay platform is essential before pursuing any further workup or treatment. If the patient is clinically euthyroid (no tachycardia, no weight loss, no tremor), this further supports laboratory artifact as the explanation.